MR spectroscopy study of dichloroacetate treatment after ischemic stroke.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11087784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a double-blind, placebo-controlled study, we used 1H MR spectroscopy to assess the effect of a single infusion of sodium dichloroacetate on lesion lactate 1 to 5 days after ischemic stroke. Apparent trends toward a reduction in lactate/N-acetyl compound ratios were seen at the higher drug doses employed, and in patients treated in the first 2 days following infarction. Use of spectroscopic measures as endpoints is feasible in acute stroke clinical trials.
Medical subject headings
- Brain Ischemia
- Dichloroacetic Acid
- Stroke